Arcutis Biotherapeutics (ARQT) Exchange Rate Effect (2023 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Exchange Rate Effect of -$119000.0 for Q1 2026, down 3075.0% year-over-year from $4000.0 in Q1 2025, and down 301.69% quarter-over-quarter from $59000.0 in Q4 2025.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Exchange Rate Effect history runs 4 years deep, the most recent figure standing at -$119000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 3075.0% year-over-year to -$119000.0; the TTM figure through Mar 2026 stood at $45000.0 (up 128.48% YoY), while the FY2025 annual figure was $168000.0, up 171.49% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$119000.0, down from $59000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $200000.0 in Q2 2025, with the low at -$234000.0 in Q4 2024.
- The 4-year median for Exchange Rate Effect is -$26000.0 (2024), against an average of -$18153.8.
- The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect soared 869.23% in 2025, then tumbled 3075.0% in 2026.
- Arcutis Biotherapeutics' Exchange Rate Effect stood at $68000.0 in 2023, then sank by 444.12% to -$234000.0 in 2024, then surged by 125.21% to $59000.0 in 2025, then plunged by 301.69% to -$119000.0 in 2026.
- Business Quant data shows ARQT's Exchange Rate Effect at -$119000.0 in Q1 2026, $59000.0 in Q4 2025, and -$95000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Arcutis Biotherapeutics | 3.12 Bn | 2.88 Bn | 118.92 Mn | -46,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -46,000.00 |
| Mar 31, 2026 | -119,000.00 |
| Dec 31, 2025 | 59,000.00 |
| Sep 30, 2025 | -95,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | -234,000.00 |
| Sep 30, 2024 | 98,000.00 |
| Jun 30, 2024 | -26,000.00 |
| Mar 31, 2024 | -73,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Sep 30, 2023 | -75,000.00 |
| Jun 30, 2023 | 9,000.00 |
| Mar 31, 2023 | -52,000.00 |